Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exjade versus Exjade + deferoxamine in children with thalassemia major
IRCT20150119020715N4Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in beta thalassemia major comparing Exjade monotherapy with Exjade + deferoxamine (2 arms). Primary endpoint: Serum ferritin level reduction. Started Sep 2016; status: completed.
02
Drugs
deferasiroxdeferoxamine
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on IRCT20150119020715N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150119020715N4.